Genetics
Neurological Genetics Tests in Dubai & UAE
Investigations in this area, with the specimen type, turnaround time and listed price for each option — so you and your clinician can compare before you book.
3 min read
- Quality-controlled laboratory
- Home collection across the UAE
- Confidential handling of results
Compare options
Neurological Genetics investigations
All 71 investigations in this category are listed below.
| Test | What it measures | Specimen | Turnaround | Price | Book |
|---|---|---|---|---|---|
| AP4E1 Gene SPG51 Genetic Test TEST-5674 LOINC 94486-1 | This test screens for pathogenic variants in the AP4E1 gene associated with hereditary spastic paraplegia type 51 (SPG51). | Peripheral Whole Blood (EDTA) or Saliva | 3–4 Weeks | 2,800.00 AED | Details |
| APOE Genotyping (Alzheimer's Disease Type 2) Genetic Test TEST-3772 LOINC 48818-7 | This genetic test identifies the APOE genotype (ε2/ε3/ε4), assessing an individual's genetic predisposition to late-onset Alzheimer's disease. | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card | 3–4 weeks | 2,800.00 AED | Details |
| ARHGEF9 Gene (Early Infantile Epileptic Encephalopathy Type 8) NGS Test TEST-4347 LOINC 103735-4 | This test identifies pathogenic variants in the ARHGEF9 gene associated with Early Infantile Epileptic Encephalopathy Type 8 (EIEE8). | Whole Blood (EDTA) or FTA Card | 21–28 working days | 2,800.00 AED | Details |
| ARSI Gene SPG66 Genetic Test TEST-5804 LOINC 95836-5 | This test analyzes the ARSI gene for pathogenic variants associated with hereditary spastic paraplegia type 66 (SPG66). It utilizes Next-Generation Se... | Peripheral whole blood (EDTA) | 3–4 weeks | 2,800.00 AED | Details |
| ATL1 Gene (SPG3A) Next‑Generation Sequencing (NGS) Genetic Test TEST-5655 LOINC 21656-8 | This test identifies pathogenic variants in the ATL1 gene associated with autosomal dominant hereditary spastic paraplegia type 3A (SPG3A). | Peripheral whole blood, extracted DNA, or DNA FTA card | 3 to 4 weeks | 2,800.00 AED | Details |
| ATL1 Gene Neuropathy, Hereditary Sensory, Type 1D Genetic Test TEST-5478 LOINC 21636-6 | This genetic test analyzes the ATL1 gene to identify mutations associated with Hereditary Sensory Neuropathy Type 1D (HSN1D). It detects single nucleo... | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) | 3–4 Weeks | 2,800.00 AED | Details |
| BEAN1 Gene Spinocerebellar Ataxia Type 31 (SCA31) Genetic Test TEST-5787 LOINC 81247-9 | This genetic test detects pathogenic repeat expansions and variants in the BEAN1 gene associated with Spinocerebellar Ataxia Type 31 (SCA31). | Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot) | 3–4 weeks from sample collection | 2,800.00 AED | Details |
| CASK Gene (FG Syndrome Type 4) Genetic Test TEST-4490 LOINC 90268-4 | This test evaluates the CASK gene for mutations associated with FG syndrome type 4, an X-linked neurodevelopmental disorder. | Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) | 3–4 Weeks | 2,800.00 AED | Details |
| CCDC88C Gene Hydrocephalus, Nonsyndromic, Autosomal Recessive Type 1 Genetic Test TEST-4530 LOINC 81247-9 | This test identifies pathogenic variants in the CCDC88C gene associated with nonsyndromic, autosomal recessive hydrocephalus type 1. | Peripheral whole blood (EDTA) or FTA card | 15–21 business days | 2,800.00 AED | Details |
| CCT5 Gene Neuropathy (Hereditary Sensory with Spastic Paraplegia) Genetic Test TEST-5483 LOINC 91553-4 | This genetic test evaluates the CCT5 gene for pathogenic variants associated with hereditary sensory neuropathy with spastic paraplegia. | Peripheral whole blood, DNA, or FTA card | 3 to 4 weeks | 2,800.00 AED | Details |
| CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test TEST-5550 LOINC 53832-6 | This test detects pathogenic mutations in the CERS1 gene associated with Progressive Myoclonus Epilepsy Type 8. | Whole blood (2–5 ml in EDTA tube) or FTA card | 3 – 4 weeks | 2,800.00 AED | Details |
| CHD2 Gene Epileptic Encephalopathy, Childhood‑Onset Genetic Test TEST-4449 LOINC 82324-3 | This genetic test identifies pathogenic variants in the CHD2 gene associated with childhood-onset epileptic encephalopathy. | Whole blood (peripheral), extracted DNA, or FTA card spot | 3–4 Weeks | 2,800.00 AED | Details |
| CHD8 Gene Autism Susceptibility Type 18 Genetic Test TEST-3892 LOINC 82320-4 | This genetic test identifies pathogenic variants within the CHD8 gene, which are associated with specific forms of autism spectrum disorder. | Peripheral whole blood (EDTA) or saliva (Oragene DNA collection kit) | 3–4 weeks | 2,800.00 AED | Details |
| CHRNA4 Gene Epilepsy, Nocturnal Frontal Lobe Type 1 Genetic Test TEST-4367 LOINC 21636-6 | This test identifies pathogenic variants in the CHRNA4 gene associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). | Peripheral Whole Blood, Extracted DNA, or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| COLQ Gene Endplate Acetylcholinesterase Deficiency Genetic Test TEST-4325 LOINC 90218-5 | This genetic test detects pathogenic variants in the COLQ gene associated with endplate acetylcholinesterase deficiency, a cause of congenital myasthe... | Peripheral Whole Blood (EDTA), Extracted Genomic DNA, or Dried Blood Spot on FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| CRBN Gene Genetic Test for Autosomal Recessive Mental Retardation Type 2 TEST-4963 LOINC 103354-1 | This test identifies pathogenic variants in the CRBN gene associated with Autosomal Recessive Intellectual Disability Type 2 (MRT2). | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card | 21–28 days (3–4 weeks) | 2,800.00 AED | Details |
| CSPP1 Gene (Joubert Syndrome Type 21) Genetic Test TEST-4665 LOINC 81260-6 | This test identifies pathogenic variants in the CSPP1 gene associated with Joubert syndrome type 21. | Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot | 3–4 Weeks (21–28 business days) | 2,800.00 AED | Details |
| CTDP1 Gene Sequencing (Cataracts, Facial Dysmorphism, Neuropathy Syndrome) Test TEST-3942 LOINC 21618-3 | This test evaluates the CTDP1 gene for variants associated with Congenital Cataracts, Facial Dysmorphism, and Neuropathy syndrome. | Peripheral whole blood (EDTA), extracted DNA, or FTA card | 3–4 weeks from sample receipt at sequencing laboratory | 2,800.00 AED | Details |
| DCC Gene Mirror Movements Type 1 Genetic Test TEST-4999 LOINC 101135-2 | This test detects pathogenic variants in the DCC gene associated with congenital mirror movements disorder. | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| DDHD1 Gene SPG28 Genetic Test TEST-5646 LOINC 91809-7 | This test evaluates the DDHD1 gene for variants associated with autosomal recessive hereditary spastic paraplegia type 28 (SPG28). | Peripheral whole blood, Extracted DNA, or FTA Card Spot | 3 to 4 Weeks | 2,800.00 AED | Details |
| DNM2 Gene DI‑CMTB Next‑Generation Sequencing (NGS) Genetic Test TEST-4210 LOINC 21636-6 | This test detects pathogenic variants in the DNM2 gene associated with Dominant Intermediate Charcot-Marie-Tooth disease type B. | Peripheral whole blood (EDTA) or saliva (Oragene DNA kit) | 3–4 Weeks | 2,800.00 AED | Details |
| DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 (EIEE23) Genetic Test TEST-4249 LOINC 81247-9 | This genetic test evaluates the DOCK7 gene for pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 23 (EIEE23). | Peripheral whole blood (EDTA) or dried blood spot (FTA card) | 3 – 4 Weeks | 2,800.00 AED | Details |
| DRD2 Gene & DYT11-Associated Dystonia NGS Panel Test TEST-4195 LOINC 69047-9 | This diagnostic test evaluates the DRD2 gene and DYT11-associated dystonia locus using Next-Generation Sequencing (NGS). It identifies pathogenic vari... | Whole Blood (EDTA) or DNA FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| DRD3 Gene Essential Tremor Type 1 Hereditary DNA Test TEST-5926 LOINC 83069-5 | This diagnostic test evaluates the DRD3 gene for pathogenic variants associated with Essential Tremor Type 1. | Whole blood (EDTA tube), extracted DNA, or dried blood spot | 3–4 weeks | 2,800.00 AED | Details |
| ENTPD1 Gene (SPG64) Next-Generation Sequencing (Genetic Test TEST-5701 LOINC 81664-5 | This test evaluates the ENTPD1 gene for variants associated with hereditary spastic paraplegia type 64. | Peripheral Whole Blood | 3–4 weeks | 2,800.00 AED | Details |
| Epilepsy Panel Genetic Test TEST-3690 LOINC 101427-9 | This test evaluates over 200 genes associated with various epileptic syndromes using next-generation sequencing. | Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) | 3–4 weeks | 3,000.00 AED | Details |
| Episodic Ataxia Comprehensive Profile (Hotspot Panel) Test TEST-1051 LOINC 81219-7 | This test identifies pathogenic variants in genes associated with episodic ataxia syndromes types 1 and 2, and related channelopathies. | Peripheral whole blood | 3–4 days (sample Monday by 11 am; report Friday) | 2,000.00 AED | Details |
| FLNA Gene (Periventricular Nodular Heterotopia, X‑Linked Dominant) Genetic Test TEST-4571 LOINC 92632-0 | This genetic test evaluates the FLNA gene for pathogenic variants associated with periventricular nodular heterotopia (PVNH), an X-linked dominant dis... | Peripheral whole blood (venous or finger-prick FTA card) | 3–4 weeks | 2,800.00 AED | Details |
| FLNA Gene Periventricular Nodular Heterotopia, Ehlers‑Danlos Variant (PNH‑ED) Genetic Test TEST-4489 LOINC 55233-1 | This test evaluates the FLNA gene for pathogenic variants associated with periventricular nodular heterotopia (PNH) and Ehlers-Danlos-like features. | Peripheral Whole Blood | 3 – 4 weeks | 2,800.00 AED | Details |
| FLRT1 Genetic Testing (SPG68) Test TEST-5704 LOINC 21636-6 | This test identifies pathogenic variants in the FLRT1 gene, which are responsible for causing autosomal recessive spastic paraplegia type 68 (SPG68).... | Whole Blood or Extracted DNA | 3–4 Weeks (21–28 Days) | 2,800.00 AED | Details |
| FUS Gene Essential Tremor Type 4 Genetic Test TEST-5830 LOINC 101388-5 | This test identifies pathogenic variants within the FUS gene associated with hereditary essential tremor type 4. | Peripheral Whole Blood | 3 to 4 weeks | 2,800.00 AED | Details |
| GABRA1 Gene (Early Infantile Epileptic Encephalopathy Type 19) Genetic Test TEST-4241 LOINC 21614-4 | This test identifies pathogenic variants in the GABRA1 gene associated with Early Infantile Epileptic Encephalopathy Type 19 (EIEE19). | Whole Blood (EDTA) or FTA Card | 3 – 4 Weeks | 2,800.00 AED | Details |
| GABRG2 Gene Generalized Epilepsy with Febrile Seizures Plus Type 3 Genetic Test TEST-4514 LOINC 94231-1 | This test identifies pathogenic variants in the GABRG2 gene associated with Generalized Epilepsy with Febrile Seizures Plus type 3 (GEFS+3). | Whole blood (EDTA tube), extracted DNA (≥1 µg), or FTA card blood spot | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| GABRG2 Gene Genetic Test (Childhood Absence Epilepsy Type 2) TEST-4334 LOINC 21623-1 | This test identifies pathogenic variants in the GABRG2 gene, which are causally linked to Childhood Absence Epilepsy Type 2 (CAE2). | Whole Blood (EDTA tube, 3–5 mL), Extracted DNA (min 1 µg), Dried Blood Spot | 3–4 Weeks | 2,800.00 AED | Details |
| GFER Gene-Related Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay Test TEST-5262 LOINC 86204-6 | This test provides definitive molecular confirmation for GFER-related mitochondrial myopathy with congenital cataract, sensorineural hearing loss, and... | Whole Blood (EDTA tube), Extracted DNA (minimum 1 µg at ≥50 ng/µL), or One Drop of Blood on FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| GRM7 Genetic Test (NGS DNA Sequencing) for Autism Spectrum, Hyperactivity, and Bipolar Disorder TEST-3888 LOINC 104197-7 | This test evaluates the GRM7 gene for pathogenic variants associated with neurodevelopmental disorders like ASD, ADHD, and bipolar disorder. | Peripheral Whole Blood | 3 to 4 weeks | 2,800.00 AED | Details |
| GUF1 Gene Early Infantile Epileptic Encephalopathy Type 40 Genetic Test TEST-4329 LOINC 81307-1 | This test identifies pathogenic variants in the GUF1 gene associated with early infantile epileptic encephalopathy type 40. | Whole blood (EDTA), Saliva, or Buccal swab | 3–4 Weeks | 2,800.00 AED | Details |
| HSD17B10 Gene (X‑Linked Mental Retardation Type 17 / HSD10 Disease) Genetic Test TEST-4910 LOINC 81257-3 | This genetic test identifies pathogenic mutations in the HSD17B10 gene associated with X-linked mental retardation type 17 (MRX17) and HSD10 mitochond... | Peripheral whole blood | 3–4 weeks | 2,800.00 AED | Details |
| HSPB1 Gene CMT2F Genetic Test TEST-4074 LOINC 55233-1 | This genetic test evaluates the HSPB1 gene for pathogenic variants associated with Charcot-Marie-Tooth disease type 2F (CMT2F), a hereditary neuropath... | Whole Blood, FTA Card (Dried Blood Spot), or Extracted DNA | 3–4 Weeks (14–21 Business Days) | 2,800.00 AED | Details |
| KCNA2 Gene Sequencing for Early Infantile Epileptic Encephalopathy Type 32 (EIEE32) Test TEST-4269 LOINC 21656-9 | This test detects pathogenic variants in the KCNA2 gene associated with Early Infantile Epileptic Encephalopathy Type 32 (EIEE32). | Peripheral whole blood, extracted DNA, or dried blood spot on FTA card | 3 – 4 Weeks (guaranteed) | 2,800.00 AED | Details |
| KCNJ18 Gene Thyrotoxic Periodic Paralysis Type 2 Genetic Test (NGS) TEST-5919 LOINC 94237-6 | This genetic test identifies pathogenic variants in the KCNJ18 gene associated with Thyrotoxic Periodic Paralysis Type 2. | Whole blood (EDTA), extracted DNA, or finger-prick dried blood spot on FTA card | 3–4 Weeks | 2,800.00 AED | Details |
| KCNQ3 Gene Seizures, Benign Neonatal, Type 2 Genetic Test TEST-5588 LOINC 81319-0 | This test evaluates the KCNQ3 gene for mutations associated with benign familial neonatal seizures type 2 (BFNS2). | Whole blood, extracted DNA, or FTA card | 3–4 weeks | 2,800.00 AED | Details |
| KCNT1 Gene Early Infantile Epileptic Encephalopathy Type 14 (EIEE14) Genetic Test TEST-4232 LOINC 93014-4 | This genetic test screens for mutations in the KCNT1 gene responsible for Early Infantile Epileptic Encephalopathy Type 14. | Whole blood, extracted DNA, or one drop blood on FTA card | 3 to 4 Weeks | 2,800.00 AED | Details |
| KIAA0586 Gene (Joubert Syndrome Type 23) Next-Generation Sequencing (Genetic Test TEST-4669 LOINC 50396-9 | This genetic test identifies pathogenic variants in the KIAA0586 gene associated with Joubert syndrome type 23. | Whole Blood, Extracted DNA, or One-drop Blood on FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| L1CAM (SPG1) Gene Sequencing Test TEST-5621 LOINC 101182-8 | This test detects pathogenic variants in the L1CAM gene associated with X-linked hereditary spastic paraplegia type 1 (SPG1). | Whole Blood (3 ml EDTA) or Dried Blood Spot (FTA card) | 3 – 4 Weeks from sample receipt | 2,800.00 AED | Details |
| L1CAM Gene MASA Syndrome Genetic Test TEST-4763 LOINC 81334-3 | This test evaluates the L1CAM gene for pathogenic variants associated with MASA syndrome. | Peripheral Whole Blood | 3 to 4 weeks | 2,800.00 AED | Details |
| MATR3 Gene Amyotrophic Lateral Sclerosis Type 21 (ALS21) Genetic Test TEST-3809 LOINC 94765-5 | This test evaluates the MATR3 gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis type 21 (ALS21). | Whole Blood (EDTA Tube) or Dried Blood Spot (FTA Card) | 3–4 weeks | 2,800.00 AED | Details |
| MTPAP Gene Spastic Ataxia Type 4 (Autosomal Recessive) Genetic Test TEST-5616 LOINC 21636-8 | This test identifies pathogenic variants in the MTPAP gene associated with autosomal recessive spastic ataxia type 4 (SPAX4). It uses Next-Generation... | Peripheral whole blood (EDTA tube) | 3–4 weeks | 2,800.00 AED | Details |
| MYOT Gene Myotilinopathy Genetic Test TEST-5278 LOINC 91247-9 | This test identifies pathogenic variants within the MYOT gene associated with myotilinopathy. | Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) | 3–4 weeks | 2,800.00 AED | Details |
| NDUFS8 Gene Leigh Syndrome Genetic Test TEST-4643 LOINC 81247-9 | This test analyzes the NDUFS8 gene to detect pathogenic variants associated with Leigh syndrome. | Whole blood (EDTA or ACD tube), buccal swab, dried blood spot (FTA card), or extracted DNA | 3 to 4 Weeks | 2,800.00 AED | Details |
| NHLRC1 Gene Myoclonic Epilepsy of Lafora Genetic Test TEST-5226 LOINC 91757-9 | This test identifies pathogenic variants in the NHLRC1 gene, associated with Lafora progressive myoclonus epilepsy. | Peripheral Whole Blood (EDTA) | 3–4 Weeks | 2,800.00 AED | Details |
| NLGN4X Gene Autism Susceptibility, X‑linked Type 2 Genetic Test TEST-3901 LOINC 96393-4 | This genetic test detects pathogenic variants, including single nucleotide variants, small indels, and copy number changes, within the NLGN4X gene. | Peripheral Blood or Dried Blood Spot (FTA Card) | 3 to 4 weeks from sample receipt | 2,800.00 AED | Details |
| PARK7 (PARK7) Gene Parkinson Disease Genetic Test TEST-5436 LOINC 94224-1 | This test identifies pathogenic variants in the PARK7 gene associated with autosomal recessive early-onset Parkinson disease. | Peripheral Whole Blood (EDTA) or Buccal Swab (FTA Card) | 3–4 weeks | 2,800.00 AED | Details |
| PCDH11X Gene Dyslexia Genetic Test TEST-4178 LOINC 94037-6 | This test evaluates the PCDH11X gene for variants associated with dyslexia susceptibility using next-generation sequencing. | Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card | 3 – 4 Weeks | 2,800.00 AED | Details |
| PLP1 Gene Sequencing for SPG2 via Next‑Generation Sequencing (NGS) Test TEST-5637 LOINC 81265-0 | This test identifies pathogenic variants in the PLP1 gene associated with Hereditary Spastic Paraplegia Type 2 (SPG2). | Peripheral whole blood (EDTA) or FTA card | 3–4 weeks (21–28 calendar days) | 2,800.00 AED | Details |
| PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test TEST-5626 LOINC 21636-6 | This test identifies pathogenic variants in the PRICKLE1 gene associated with Progressive Myoclonus Epilepsy Type 1A. | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| PRKN (PARK2) Gene Parkinson Disease Genetic Test TEST-5423 LOINC 82498-8 | This test evaluates the PRKN (PARK2) gene for pathogenic variants associated with early-onset Parkinson disease. | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) | 3 – 4 Weeks | 2,800.00 AED | Details |
| PSEN1 Gene Pick Disease Genetic Test TEST-5480 LOINC 21636-6 | This test identifies pathogenic variants in the PSEN1 gene associated with Pick disease and frontotemporal dementia. | Whole Blood (EDTA) or FTA Card | 3 – 4 Weeks | 2,800.00 AED | Details |
| RABGGTA Gene Autism Spectrum Disorder Genetic Test TEST-3852 LOINC 101420-0 | This test evaluates the RABGGTA gene for pathogenic variants linked to syndromic autism spectrum disorder using next-generation sequencing. | Peripheral Whole Blood | 3 to 4 weeks | 2,800.00 AED | Details |
| RNF39 Gene Genetic Test (Hippocampal Long-Term Potentiation) TEST-4495 LOINC 21752-8 | This genetic test evaluates variants in the RNF39 gene associated with altered hippocampal long-term potentiation and neuroplasticity. | Peripheral Whole Blood (EDTA tube) | 3–4 Weeks | 2,800.00 AED | Details |
| SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test TEST-4510 LOINC 21636-6 | This test evaluates the SCN1B gene for variants associated with Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+). It identifies mutation... | 3 mL whole blood in EDTA (lavender-top tube), or 5 µg extracted DNA (≥10 ng/µL), or one drop blood on FTA card | 10–14 business days (3–4 calendar weeks) | 2,800.00 AED | Details |
| SCN2A Gene (Early Infantile Epileptic Encephalopathy Type 11) Genetic Test TEST-4281 LOINC 83190-8 | This genetic test detects pathogenic variants in the SCN2A gene associated with Early Infantile Epileptic Encephalopathy Type 11. | Blood (2-3 mL EDTA), Extracted DNA, or FTA Card | 3–4 Weeks (Comprehensive Report) | 2,800.00 AED | Details |
| SCN8A Gene Early Infantile Epileptic Encephalopathy Type 13 Genetic Test TEST-4285 LOINC 94231-8 | This test identifies pathogenic variants in the SCN8A gene associated with Early Infantile Epileptic Encephalopathy Type 13. | Whole blood (EDTA), extracted genomic DNA, or dried blood on FTA card | 3 to 4 Weeks | 2,800.00 AED | Details |
| SGCE Gene DYT11 (Myoclonus-Dystonia) Genetic Test TEST-4243 LOINC 97961-3 | This test evaluates the SGCE gene for mutations associated with myoclonus-dystonia syndrome (DYT11). It uses Next-Generation Sequencing (NGS) to provi... | Peripheral Blood, Saliva (Oragene OG-500), or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| SLC2A1 Gene GLUT1 Deficiency Genetic Test TEST-4219 LOINC 81329-1 | This test identifies pathogenic variants in the SLC2A1 gene, which are responsible for GLUT1 deficiency syndrome, a metabolic disorder affecting gluco... | Peripheral Whole Blood or Oral Mucosa (FTA Card) | 3–4 weeks | 2,800.00 AED | Details |
| SLC6A3 Gene Parkinsonism-Dystonia Infantile Genetic Test TEST-5446 LOINC 83091-6 | This test identifies pathogenic variants in the SLC6A3 gene associated with dopamine transporter deficiency syndrome (infantile parkinsonism-dystonia)... | Whole Blood (Venous or Heel-Prick) | 3–4 Weeks | 2,800.00 AED | Details |
| SYNGAP1-Related Intellectual Disability (Autosomal Dominant Type 5) Genetic Test TEST-4945 LOINC 90396-6 | This test identifies pathogenic variants in the SYNGAP1 gene, confirming a diagnosis of SYNGAP1-related intellectual disability. | Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| TGM6 Gene Sequencing Test for Spinocerebellar Ataxia Type 35 (SCA35), Autosomal Dominant TEST-5888 LOINC 55233-1 | This test identifies pathogenic variants in the TGM6 gene associated with Spinocerebellar Ataxia Type 35 (SCA35). It uses Next-Generation Sequencing (... | Whole blood (EDTA) | 3–4 Weeks | 2,800.00 AED | Details |
| TREM2 Gene Sequencing for Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (Nasu-Hakola Disease) Test TEST-5571 LOINC 81424-7 | This test analyzes the TREM2 gene for mutations associated with Nasu-Hakola disease (PLOSL). It identifies pathogenic variants causing the disorder. | Peripheral Whole Blood (3–5 mL in EDTA Lavender-Top Tube) | 21–28 calendar days (3–4 weeks) | 2,800.00 AED | Details |
| ULK2 Gene (Smith-Magenis Syndrome) Genetic Test TEST-5698 LOINC 81247-9 | This test identifies pathogenic variants in the ULK2 gene associated with Smith-Magenis syndrome. | Peripheral Whole Blood (EDTA) | 3 to 4 Weeks | 2,800.00 AED | Details |
| ZFHX4 Gene (Congenital Ptosis) Genetic Test TEST-5554 LOINC 55233-1 | This test identifies pathogenic variants in the ZFHX4 gene associated with congenital ptosis. | Peripheral whole blood (EDTA) | 3 – 4 weeks | 2,800.00 AED | Details |
Clinical overview
About Neurological Genetics
Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurological Genetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurological genetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.
Before your appointment
Preparation & sample collection
Follow the instructions you are given
Fasting, timing and medicine restrictions differ between investigations. The instructions for your specific request are confirmed when you book.
Bring your identification
A valid photo ID is required at collection so that your sample is matched correctly to your record.
Tell us about medicines
Prescription medicines, supplements and recent procedures can affect how an investigation is scheduled or interpreted — please mention them.
Ask before collection
If anything about preparation is unclear, contact us before your appointment. Preparation errors can affect reporting times.
Patient information
Frequently asked questions
Practical answers about Neurological Genetics testing at DNA Labs UAE. This information is general and does not replace advice from your treating clinician.
How do I choose the right Neurological Genetics test?
The correct investigation depends on what your clinician is trying to establish. Review the specimen type and turnaround time below, then confirm the choice with your treating doctor before booking.
What specimen is required?
Specimen requirements are listed for each investigation. If a request involves more than one sample type, our team will confirm what is needed at the time of booking.
Do you offer home sample collection in Dubai and the UAE?
Yes. Home collection can be arranged across Dubai and the wider UAE. Availability and appointment windows vary by location, so please confirm when you book.
How long do results take?
Turnaround depends on the investigation and the method used. The expected reporting time is confirmed with you before collection.
Is there anything I need to do before sample collection?
Some investigations require fasting, a specific collection time, or avoiding certain medicines or activities. Preparation details are shared when you book — please follow them and ask if anything is unclear.
How will I receive my report?
Reports are issued as secure digital documents and can be shared with your referring clinician on request. Please review results with a qualified clinician who can interpret them in context.
About this clinical information
The information on this Neurological Genetics page describes laboratory investigations in general terms. It is written to help you understand what an investigation involves — it is not a diagnosis and it is not a substitute for advice from your treating clinician.
- Investigation names, specimen types and listed prices are reviewed against laboratory records.
- Preparation guidance is indicative — confirm test-specific instructions before collection.
- Content is updated when investigations, methods or reporting formats change.
- Results are released to the patient and, on request, shared with the referring clinician.
Medical disclaimer: This page is for general information and education only. It is not medical advice, diagnosis or treatment, and it does not replace a consultation with a qualified healthcare professional. Always seek the advice of your doctor or another qualified provider with any questions about a medical condition or before ordering a test.
We're here to help
Need help choosing a Neurological Genetics test?
Tell us what your clinician has requested and we'll confirm availability, price, preparation and the most convenient collection option — including home collection in Dubai and across the UAE.
- Home collection available across the UAE
- Digital reports delivered securely
- Confidential handling of every request
Related areas